Jeffrey H Knapp Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey H Knapp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey H Knapp. Jeffrey H Knapp is a Senior VP, Sales & Marketing in ABGENIX INC ($ABGX) and a Sr. VP, Sales and Marketing in ABGENIX INC ($ABGX) and a Chief Operating Officer in Adamas Pharmaceuticals Inc ($ADMS) and a Chief Operating Officer in Aimmune Therapeutics, Inc. ($AIMT).
Address: 6701 KAISER DRIVE FREMONT 94555 CA
Companies in which Jeffrey H Knapp is an Insider
ABGENIX INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Jeffrey H Knapp: Senior VP, Sales & Marketing, Sr. VP, Sales and Marketing
Holdings: 0 shares
Latest Transaction: Apr 04 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Adamas Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey H Knapp: Chief Operating Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 27 2015
$ADMS Market Capitalization: $364.02M
$ADMS Previous Close: $16.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aimmune Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jeffrey H Knapp: Chief Operating Officer
Holdings: 12,151 shares
Current Value: $226,738
Latest Transaction: Mar 06 2018
$AIMT Market Capitalization: $796.78M
$AIMT Previous Close: $18.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Jeffrey H Knapp
Sentiment: All, ABGX, ADMS, AIMT
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Knapp Jeffrey H | Chief Operating Off ... | Option Exercise | A | 34.07 | 56,250 | 1,916,438 | 56,250 | |
| Mar 06 2018 | AIMT | Aimmune Therapeuti ... | Knapp Jeffrey H | Chief Operating Off ... | Grant | A | 0.00 | 9,375 | 0 | 12,151 | 2.8 K to 12.2 K (+337.72 %) |
| Feb 24 2017 | AIMT | Aimmune Therapeuti ... | Knapp Jeffrey H | Chief Operating Off ... | Option Exercise | A | 19.63 | 90,000 | 1,766,700 | 90,000 | |
| Feb 03 2017 | AIMT | Aimmune Therapeuti ... | Knapp Jeffrey H | Chief Operating Off ... | Payment of Exercise | F | 17.89 | 2,224 | 39,787 | 2,776 | 5 K to 2.8 K (-44.48 %) |
| Feb 26 2016 | AIMT | Aimmune Therapeuti ... | Knapp Jeffrey H | Chief Operating Off ... | Option Exercise | A | 16.93 | 250,000 | 4,232,500 | 250,000 | |
| Feb 26 2016 | AIMT | Aimmune Therapeuti ... | Knapp Jeffrey H | Chief Operating Off ... | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
| Feb 27 2015 | ADMS | Adamas Pharmaceuti ... | Knapp Jeffrey H | Chief Operating Off ... | Option Exercise | A | 17.31 | 65,000 | 1,125,150 | 65,000 |